Palomino Laboratories (PALX) Total Liabilities (2022 - 2025)
Palomino Laboratories' (PALX) quarterly Total Liabilities came in at $336458.0 in Q4 2025, up 115.08% year-on-year from $156431.0 in Q4 2024, and down 66.32% quarter-over-quarter from $999013.0 in Q3 2025.
Palomino Laboratories (PALX) Total Liabilities (2022 - 2025) Analysis & Trends
Palomino Laboratories has disclosed Total Liabilities across 4 years of filings, most recently posting $336458.0 for Q4 2025.
- Total Liabilities for Q4 2025 came in at $336458.0, up 115.08% year-over-year; the trailing twelve-month figure through Dec 2025 was $336458.0 (up 115.08% YoY), and the FY2025 annual result was $336458.0, up 115.08% from the prior year.
- Total Liabilities came in at $336458.0 for Q4 2025 at Palomino Laboratories, down from $999013.0 in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $999013.0 in Q3 2025 to a low of $27804.0 in Q4 2022.
- The 4-year median for Total Liabilities is $162925.0 (2024), against an average of $235268.4.
- Peak annual rise in Total Liabilities reached 443.68% in 2024, while the deepest fall reached 40.14% in 2024.
- Palomino Laboratories' Total Liabilities stood at $27804.0 in 2022, then surged by 301.46% to $111621.0 in 2023, then soared by 40.14% to $156431.0 in 2024, then jumped by 115.08% to $336458.0 in 2025.
- The last three Total Liabilities figures came in at $336458.0 (Q4 2025), $999013.0 (Q3 2025), and $364431.0 (Q2 2025), per Business Quant data.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 336,458.00 |
| Sep 30, 2025 | 999,013.00 |
| Jun 30, 2025 | 364,431.00 |
| Mar 31, 2025 | 336,989.00 |
| Dec 31, 2024 | 156,431.00 |
| Sep 30, 2024 | 221,754.00 |
| Jun 30, 2024 | 194,658.00 |
| Mar 31, 2024 | 162,925.00 |
| Dec 31, 2023 | 111,621.00 |
| Sep 30, 2023 | 79,047.00 |
| Jun 30, 2023 | 35,804.00 |
| Mar 31, 2023 | 31,554.00 |
| Dec 31, 2022 | 27,804.00 |